Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for Dural Tears in Spine Surgery
NCT07876713Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Apr 2025
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
A Phase 4 trial of acetazolamide in cerebrospinal fluid leak, Dural tear, sponsored by Ain Shams University. Started Apr 2025; status: completed.
02
Drugs
acetazolamide
03
Conditions
cerebrospinal fluid leakDural tear
Beyond the preview
Go deeper on NCT07876713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07876713.